Flow Cytometry Market - Industry Size, Share & Analysis
The global flow cytometry market is estimated to reach $7 billion by 2022, registering a CAGR of 16.0% over the forecast period 2014‐2022. Flow cytometry is a biophysical, laser-based analytical technology that measures and analyzes several physical characteristics of cells or particles suspended in a fluid, when passed through a laser beam. Flow cytometry has various advantages over traditional analytical methods such as ELISA, which includes its ability to deliver precise and accurate results, and lesser time consumption at about same prices. The flow cytometry technology is widely used in various fields of academic and clinical research, and diagnosis of diseases such as cancer, HIV, and hematological malignancies. The rising count of patients suffering from HIV and cancer, and increasing use of flow cytometry in hospitals and diagnostic centers, has created an impending need for flow cytometry in the effective diagnosis as well as monitoring of diseases. The term flow cytometry as well as fluorescence-activated cell sorting are often interchangeable. FACS or fluorescence activated cell sorting used in flow cytometry have ensured a strong market future.
Global flow cytometry market size is set to grow at a remarkable pace in the coming years, attributed to technological advancements and high adoption in various research and diagnostic applications. In addition, the advent of flow cytometry technology in novel research applications, such as cytogenomics, proteomics, and marine cell biology would further supplement the industry’s growth. Further, rising incidence rates of diseases such as cancer and HIV are likely to boost the adoption of flow cytometry technology across diagnostic applications. On the other hand, factors such as high cost associated with instruments and reagents, lack of awareness among potential end users, and the limited availability of technical expertise are likely to impede the flow cytometry market growth. The preference of flow cytometry analysis in drug discovery & development and diagnostics is expected to provide numerous growth opportunities.
The report segments the global flow cytometry industry based on components, technologies, applications, end users, and geography. Based on cell components, the market is segmented into instruments, reagents, software and services. Instruments accounted for the highest revenue-generating segment in 2014, owing to the technological advancements, demand for highly efficient replaceable components, and widening the scope of flow cytometry applications in newer diseases. Based on technology, the market is segmented into bead based and cell-based technologies. Cell-based flow cytometry would constitute the highest revenue generating segment throughout the forecast period due to its widespread use across all the applications. Based on application, the market is segmented into academic & clinical research and diagnostic applications. Academic and clinical research application were the major revenue generating segment in 2014. However, the diagnostics segment is projected as the fastest growing segment. The flow cytometry end-users market is segmented into commercial organizations, medical schools and labs, hospitals, academics and others. Commercial organizations were the highest revenue generating end-user segment in 2014, due to high adoption of flow cytometry in drug discovery process, clinical pathology, and research.
Based on geography, the market is segmented across North America, Europe, Asia-Pacific, and LAMEA. North America was the leading region in 2014, supplemented by rapid technological advancements, high R&D investment, and widespread use of flow cytometry in diagnostic activities. Asia-Pacific region would emerge as the most lucrative market over the forecast period owing to the outsourcing of R&D activities in this region and increasing incidences of diseases such as cancer and HIV.
The report provides a comprehensive analysis of the leading companies operating in the flow cytometry industry. Key companies profiled in the report are Danaher Corporation (Beckman Coulter), Becton, Dickinson and Company, EMD Millipore, Sysmex Corporation, Affymetix Inc., Luminex Corporation, Thermo Fischer Scientific, Bio-Rad Laboratories, Inc., Miltenyi Biotec, Inc. and Agilent Technologies, Inc.
FLOW CYTOMETRY MARKET KEY BENEFITS:
- The study provides an in-depth analysis of the clinical flow cytometry market share, size with current and future trends to elucidate the imminent investment pockets in the market.
- The report provides a quantitative analysis through 2014-2022, which would enable the stakeholders to capitalize on prevailing market opportunities.
- The flow cytometry market analysis on an extensive level, by component, helps in understanding the components of the flow cytometer that are currently used along with the variants that would gain prominence in the future.
- Complete overview of Competitive intelligence highlights the business practices followed by leading market players across various geographies.
- SWOT analysis enables to study the internal and external environment of the leading companies for strategy formulation.
FLOW CYTOMETRY MARKET KEY SEGMENTS:
The global market is segmented as:
- Cytometry platforms
- Replaceable components
- Reagents and consumables
- Cytometry platforms
- Bead based flow cytometry
- Cell based flow cytometry
- Academic and clinical research applications
- Cell cycle analysis and cell proliferation
- Sorting and screening
- Transfection and cell viability
- Diagnosis applications
- Organ transplantation
- Hematological malignancies
- Cancer and solid tumors
- Immunodeficiency diseases- HIV infection
By End users
- Commercial organizations
- Medical schools and clinical labs
- North America